• Monthly News Review of PharmaSources (February) - Business Caicai/PharmaSources
    March 14, 2023
    On the business, Keymed Biosciences Inc. and Lepu Biopharma jointly announced an exclusive global licensing agreement with AstraZeneca for CMG901. In terms of the listing, Kelun Pharmaceutical's subsidiary Kelun Biotech intends to go public in Hong Kong.
  • How Hot is the Third-generation EGFR-TKI? PharmaSources/Caicai
    April 03, 2019
    BPI-7711 is a third-generation EGFR-TKI, making Beta Pharma the fourth Chinese pharmaceutical enterprises that enter the Phase III clinical trial of the variety following ACEA, Hansoh, and Allist.
PharmaSources Customer Service